These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22013563)

  • 1. Difluprednate for inflammatory eye disorders.
    Mulki L; Foster CS
    Drugs Today (Barc); 2011 May; 47(5):327-33. PubMed ID: 22013563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
    Foster CS; Davanzo R; Flynn TE; McLeod K; Vogel R; Crockett RS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):475-83. PubMed ID: 20809807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure elevation from topical difluprednate use.
    Meehan K; Vollmer L; Sowka J
    Optometry; 2010 Dec; 81(12):658-62. PubMed ID: 21111374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
    Sheppard JD; Toyos MM; Kempen JH; Kaur P; Foster CS
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2993-3002. PubMed ID: 24677110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
    Donnenfeld ED; Holland EJ; Solomon KD; Fiore J; Gobbo A; Prince J; Sandoval HP; Shull ER; Perry HD
    Am J Ophthalmol; 2011 Oct; 152(4):609-617.e1. PubMed ID: 21704965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Korenfeld MS; Silverstein SM; Cooke DL; Vogel R; Crockett RS;
    J Cataract Refract Surg; 2009 Jan; 35(1):26-34. PubMed ID: 19101421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
    Tijunelis MA; Person E; Niziol LM; Musch DC; Ernest P; McBain M; Mian SI
    J Cataract Refract Surg; 2017 Feb; 43(2):223-227. PubMed ID: 28366370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies.
    Sheppard JD; Foster CS; Toyos MM; Markwardt K; Da Vanzo R; Flynn TE; Kempen JH
    Ocul Immunol Inflamm; 2019; 27(3):484-496. PubMed ID: 29260952
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
    Tajika T; Isowaki A; Sakaki H
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and potential complications of difluprednate use for pediatric uveitis.
    Slabaugh MA; Herlihy E; Ongchin S; van Gelder RN
    Am J Ophthalmol; 2012 May; 153(5):932-8. PubMed ID: 22265149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis.
    KhalafAllah MT; Basiony A; Salama A
    BMJ Open; 2019 Nov; 9(11):e026752. PubMed ID: 31678934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®).
    Quantz K; Anderson AL; Harman CD; Noland EL; Del Valle JM; Occelli LM; Burn JB; Petersen-Jones SM; Langlois DK; Pirie CG; Petersen AD; Komáromy AM
    BMC Vet Res; 2021 Dec; 17(1):366. PubMed ID: 34847929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topically administered 0.05% difluprednate and 1% prednisolone acetate for inhibition of aqueocentesis-induced breakdown of the blood-aqueous barrier in healthy dogs.
    Allbaugh RA; Wehrman RF; Sebbag L
    Am J Vet Res; 2020 Mar; 81(3):260-266. PubMed ID: 32101036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    Verhoeven RS; Garcia A; Robeson R; Gilger BC; Culp D; Struble C; Hamm L; Navratil T; Yerxa B
    J Ocul Pharmacol Ther; 2018; 34(1-2):161-169. PubMed ID: 28650720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical difluprednate monotherapy for uveitic macular edema.
    Symes RJ; Forooghian F
    Can J Ophthalmol; 2016 Feb; 51(1):47-9. PubMed ID: 26874159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiles of difluprednate in rabbit ocular tissues after instillation of difluprednate ophthalmic emulsion.
    Tajika T; Takahashi H; Sakai Y; Fujii H; Isowaki A; Sakaki H
    Xenobiotica; 2010 Aug; 40(8):569-77. PubMed ID: 20509750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits.
    Kakimoto H; Takamura Y; Arimura S; Miyake S; Matsumura T; Gozawa M; Iwasaki K; Morioka M; Yamada Y; Inatani M
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):410-415. PubMed ID: 29812993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis.
    Kurz PA; Chheda LV; Kurz DE
    Ocul Immunol Inflamm; 2011 Feb; 19(1):84-5. PubMed ID: 21034305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate.
    Birnbaum AD; Jiang Y; Tessler HH; Goldstein DA
    Arch Ophthalmol; 2011 May; 129(5):667-8. PubMed ID: 21555625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.